Nanobiotix S.A.
NBTX • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.58B
Growth
-2.5%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 68.9%Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Oct 1, 2026, 12:07 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$1.58B
52W Range14.78 - 57.14
Beta0.57
Gross Margin100.00%
Oper. Margin-36.49%
Profit Margin-80.83%
Debt/Eq-1.13
Current Ratio1.09
Quick Ratio1.09
Revenue 5Y-2.52%
Price$0.00
Change0.00%
Market Cap$1.58B
52W Range14.78 - 57.14
Beta0.57
Gross Margin100.00%
Oper. Margin-36.49%
Profit Margin-80.83%
Debt/Eq-1.13
Current Ratio1.09
Quick Ratio1.09
Revenue 5Y-2.52%
Target$38.00
Target Median$38.00
Target Range30.00 - 46.00
Volume311.37K
Avg Volume122.42K
EPS Surprise-0.76
Investment DNA
How strong this company looks for long-term investors
39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
48/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive revenue growth · 68.9%Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-10-01
Low
$30.00
Mean
$38.00
Median
$38.00
High
$46.00
🧾
No insider activity
No recent insider transactions available.